Skip to main content
. 2013 Jun 4;80(23):2106–2111. doi: 10.1212/WNL.0b013e318295d789

Figure 2. Sphingoid (A) and deoxysphingoid (B) base levels.

Figure 2

1-Deoxysphingolipids in plasma of patients and healthy controls. Significantly elevated 1-deoxysphingolipid levels were found for patients carrying the SPTLC2-A182P mutation. Data are shown as means, with error bars representing SDs. SDs were calculated using 1-way analysis of variance with Bonferroni multiple correction. n.s. = not significant; SA = sphinganine; SO = sphingosine. ***p < 0.001; ****p < 0.0001.

HHS Vulnerability Disclosure